Use of siRNA targeting NRP1 significantly reduces tumor growth, angiogenesis, metastasis formation in various human cancer models, such as hepatocellular carcinoma [145,146], acute myeloid leukemia [67], lung cancer [147]. Here, NRP1 is linked to cancer.